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Background
TMS is a safe stimulation technique of the brain with anti-
depressive activity, but there are limited data in clinical
psychiatry on application of rTMS in schizophrenia.
Depression is an important co-occurring syndrome in
schizophrenia and is associated with increased morbidity
and mortality. The aim of our study was to estimate the
effect of rTMS for depression in schizophrenia.
Materials and methods
32 patients with schizophrenia (ICD-10) without exacer-
bation of psychotic symptoms and with marked depres-
sion (CDSS score >6). All patients were on stabile
medication for at least 4 weeks before and throughout the
rTMS treatment. 15 Hz rTMS at 100% of MT was adminis-
tered over the left dorsolateral prefrontal cortex. The
Neuro-MS stimulator (Ivanovo, Russia) with figure-eight
coil was used for 5-20 sessions within a three-week
period. Each session consisted of 20 6-second trains with
1 minute intervals (1800 stimuli per session). Patients
were assessed weekly by CDSS, HAMD, CGI, PANSS and
battery of cognitive tests.
Results
The number of responders (50% reduction of CDSS score)
at the end of rTMS treatment were 20 (62,5%). The clini-
cal effect of rTMS appeared at the end of the first week.
Negative symptoms of PANSS also were decreased during
rTMS treatment (29,8% reduction after 3 weeks) without
significant changes in positive symptoms. Cognitive tests
showed improvement in executive functions and atten-
tion switching but there weren't any significant changes in
verbal and visual memory.
Conclusions
Our preliminary data confirm that rTMS is effective in the
treatment of depression in patients with schizophrenia.
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